Back to Browse Journals » Clinical Interventions in Aging » Volume 3 » Issue 3

HIV infection in the elderly

Authors Nancy Nguyen, Mark Holodniy

Published 12 September 2008 Volume 2008:3(3) Pages 453—472


Nancy Nguyen1, Mark Holodniy2

1University of the Pacific School of Pharmacy and Health Sciences, Stockton, CA, USA; 2VA Palo Alto Health Care System, Palo Alto, CA, USA

Abstract: In the US, an estimated 1 million people are infected with HIV, although one-third of this population are unaware of their diagnosis. While HIV infection is commonly thought to affect younger adults, there are an increasing number of patients over 50 years of age living with the condition. UNAIDS and WHO estimate that of the 40 million people living with HIV/AIDS in the world, approximately 2.8 million are 50 years and older. With the introduction of highly active antiretroviral therapy (HAART) in the mid-1990s, survival following HIV diagnosis has risen dramatically and HIV infection has evolved from an acute disease process to being managed as a chronic medical condition. As treated HIV-infected patients live longer and the number of new HIV diagnoses in older patients rise, clinicians need to be aware of these trends and become familiar with the management of HIV infection in the older patient. This article is intended for the general clinician, including geriatricians, and will review epidemiologic data and HIV treatment as well as provide a discussion on medical management issues affecting the older HIV-infected patient.

Keywords: HIV, epidemiology, treatment, aging, review

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at:

Other article by this author:

Influenza treatment and prophylaxis with neuraminidase inhibitors: a review

Kamali A, Holodniy M

Infection and Drug Resistance 2013, 6:187-198

Published Date: 19 November 2013

Readers of this article also read:

Novel nanostructured biomaterials: implications for coronary stent thrombosis

Karagkiozaki V, Karagiannidis PG, Kalfagiannis N, Kavatzikidou P, Patsalas P, Georgiou D, Logothetidis S

International Journal of Nanomedicine 2012, 7:6063-6076

Published Date: 17 December 2012

Mechanisms of greater cardiomyocyte functions on conductive nanoengineered composites for cardiovascular applications

Stout DA, Yoo J, Noemi Santiago-Miranda A, Webster TJ

International Journal of Nanomedicine 2012, 7:5653-5669

Published Date: 13 November 2012

Gold nanoparticle trapping and delivery for therapeutic applications

Aziz MS, Suwanpayak N, Jalil MA, Jomtarak R, Saktioto T, Ali J, Yupapin PP

International Journal of Nanomedicine 2012, 7:11-17

Published Date: 29 December 2011

Luteinizing hormone-releasing hormone receptor-mediated delivery of mitoxantrone using LHRH analogs modified with PEGylated liposomes

Yingna He, Linhua Zhang, Cunxian Song

International Journal of Nanomedicine 2010, 5:697-705

Published Date: 20 September 2010

Death and dying in the US: the barriers to the benefits of palliative and hospice care

Albert J Finestone, Gail Inderwies

Clinical Interventions in Aging 2008, 3:595-599

Published Date: 12 September 2008

Testosterone replacement therapy for older men

Stephen E Borst, Thomas Mulligan

Clinical Interventions in Aging 2007, 2:561-566

Published Date: 15 January 2008

The management of hemophilia in elderly patients

Massimo Franchini, Annarita Tagliaferri, Pier Mannuccio Mannucci

Clinical Interventions in Aging 2007, 2:361-368

Published Date: 15 October 2007